FDA Announces New Labeling Guidelines For Longer Acting Painkillers

Forbes: In response to increasing numbers of deaths, injuries, and addiction stemming from prescription painkiller abuse, the FDA has issued new labeling guidelines for medical providers who prescribe longer acting painkillers, commonly referred to as opoids.

Read article

Share